Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 83,662 |
|
|||||
| News | - | ||||||
| Day High | 6.94 | Low High |
|||||
| Day Low | 6.75 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Fennec Pharmaceuticals Inc | FENC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.01 | 0.15% | 6.86 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.77 | 6.75 | 6.94 | 6.86 | 6.85 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,106 | 83,662 | $ 6.84 | $ 572,380 | - | 6.30 - 11.92 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:32:29 | 20 | $ 6.82 | USD |
Fennec Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 251.68M | 26.63M | - | 21.25M | -16.05M | -0.60 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Fennec Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FENC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.82 | 7.00 | 6.58 | 6.75 | 110,960 | 0.04 | 0.59% |
| 1 Month | 9.85 | 10.0657 | 6.51 | 7.23 | 238,710 | -2.99 | -30.36% |
| 3 Months | 9.92 | 11.49 | 6.51 | 8.90 | 174,757 | -3.06 | -30.85% |
| 6 Months | 9.07 | 11.92 | 6.51 | 9.40 | 146,854 | -2.21 | -24.37% |
| 1 Year | 8.49 | 11.92 | 6.30 | 8.91 | 125,872 | -1.63 | -19.20% |
| 3 Years | 7.44 | 11.92 | 3.8219 | 7.97 | 104,080 | -0.58 | -7.80% |
| 5 Years | 3.66 | 11.92 | 3.255 | 7.53 | 118,540 | 3.20 | 87.43% |
Fennec Pharmaceuticals Description
| Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. |
